Literature DB >> 14133581

STUDIES IN ACTIVITY LEVEL. VII. EFFECTS OF AMPHETAMINE DRUG ADMINISTRATION ON THE ACTIVITY LEVEL OF RETARDED CHILDREN.

T R MCCONNELL, R L CROMWELL.   

Abstract

Entities:  

Keywords:  ADOLESCENCE; AMPHETAMINE; CHILD; MENTAL RETARDATION; MOVEMENT DISORDERS; PLACEBOS

Mesh:

Substances:

Year:  1964        PMID: 14133581

Source DB:  PubMed          Journal:  Am J Ment Defic        ISSN: 0002-9351


× No keyword cloud information.
  8 in total

1.  A free space-time traversal data-logging system for two human subjects.

Authors:  M J MacCulloch; C J Birtles; S Bond
Journal:  Med Biol Eng       Date:  1969-11

Review 2.  Predicting the response of hyperkinetic children to stimulant drugs: a review.

Authors:  R A Barkley
Journal:  J Abnorm Child Psychol       Date:  1976

3.  Activity level: a comparison between actometer scores and observer ratings.

Authors:  T M Stevens; M J Kupst; B G Suran; J L Schulman
Journal:  J Abnorm Child Psychol       Date:  1978-06

4.  The assessment of impulsivity and mediating behaviors in hyperactive and nonhyperactive boys.

Authors:  M Gordon
Journal:  J Abnorm Child Psychol       Date:  1979-09

Review 5.  The hyperkinetic child: some misleading assumptions.

Authors:  P S Stephenson
Journal:  Can Med Assoc J       Date:  1975-10-18       Impact factor: 8.262

Review 6.  Stimulant drug effects in developmental disorders and hyperactivity--toward a resolution of disparate findings.

Authors:  M G Aman
Journal:  J Autism Dev Disord       Date:  1982-12

7.  Comparison of the effects of chlorpromazine, dextroamphetamine and methylphenidate on the behaviour and intellectual functioning of hyperactive children.

Authors:  G Weiss; K Minde; V Douglas; J Werry; D Sykes
Journal:  Can Med Assoc J       Date:  1971-01-09       Impact factor: 8.262

8.  Absence of hyperactivity in lead-exposed developing rats.

Authors:  D Krehbiel; G A Davis; L M LeRoy; R E Bowman
Journal:  Environ Health Perspect       Date:  1976-12       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.